1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Sepsis Diagnostics: Global Markets

Sepsis Diagnostics: Global Markets

  • April 2022
  • 114 pages
  • ID: 6272716
  • Format: PDF
  • BCC Research


Table of Contents

Report Scope:
The current report provides detailed exposure to the sepsis diagnostic market.This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities.

The report also covers market projections to 2026 and market shares for key market players.It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type.

The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.

The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.

Report Includes:
- 35 data tables and 15 additional tables
- An updated overview of the global sepsis diagnostics market
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
- Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
- Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
- Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
- Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.

Sepsis is a life-threatening conditionmarked by severe organ dysfunction.According to theWorld Health Organization’s (WHO) GlobalReport on the Epidemiology and Burden of Sepsis, therewere 49 million cases and 11 million sepsis-related deaths in 2017, accounting for nearly 20% of all annual global deaths.

Sepsis is considered as the common pathway to death for severaldiseases, including infectious diseases.In the recent report on sepsis, the WHO observed that even non-communicable or chronic diseases and injuries can also lead to sepsis.

Studies indicate that the incidence of sepsis is increasing, but the mortality rate is decreasing.The burden of the disease, however, is very high in low-and middleincome countrieswith poor healthcare infrastructures.

Elderly patients, neonates and immunocompromised patients are at high risk of sepsis.

Sepsis is also associatedwith high economic burden and is the most expensive condition forhospitalized patients. For this reason, theWHO andWorld Health Assembly (WHA) have adopted a resolution in 2017 to improve, prevent, diagnose andmanage sepsis.

There is no specific laboratory test to diagnose sepsis. The current diagnosis is based on various technologies, including microbiological tests,moleculardiagnostics and biomarkers.Microbiological tests are the most preferredmethod. Despite advances in the molecular diagnostic methods, blood culture is considered the gold standard for the diagnosis of sepsis.Molecular techniques have been limited due to high cost and the need for a skilled workforce.Microbial identification is restricted to the specified panels used in the technique. The blood culture method has both advantages and limitations. Blood cultures are time consuming and may result in false negatives. It is for this reason that there is
high need for a rapid and accurate diagnostic method. Thus, there is scope forpoint-of-care tests that would be helpful in bedside sepsis diagnosis. Rapid diagnosis and early treatment lead to betterpatient outcomes, with survival rates are as high as 80%. Delay in diagnosis also leads to increased risk of antimicrobial resistance, as patientswith sepsis are initially startedwith antimicrobials. It is based on the culture results that physicians start with targeted antimicrobials and look into escalation or deescalation of the ongoing antimicrobial therapy.

Thus, increasing prevalence, awareness and various government initiativeswill lead to growth in the sepsis diagnostic market.The market has also witnessed technologicaladvancementswith novel instruments that usewhole blood fordetection and do not rely on positive blood cultures.

Research is also focused on studying the benefit of biomarker combinations, as each biomarker represents a different aspect of sepsis andwould help in early detection. Research is focused on microfluidics, machine learning and artificial intelligence tools for rapid diagnosis.

The global market for sepsis diagnosticswas estimated to be REDACTED in 2020, and the market is expected to increase to nearly REDACTED through 2026, growing at a compound annual growth rate (CAGR) of REDACTED during the forecast period.Majorplayers in the market include BioMerieux, Becton, Dickinson and Company, DanaherCorporation, Thermo Fisher Scientific, T2 Biosystems, Luminex, Roche Diagnostics, BrukerCorporation, Abbott Laboratories and Immunexpress.

In this report, the market is segmented based on technology, product,method, test, pathogen, end user and region. The North Americanmarket currently holds the highestmarket share, followed by Europe.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Hemostasis Analyzers Global Market Report 2022

  • $ 5000
  • May 2022
  • 200 pages

Major players in the hemostasis analyzers market are Thermo Fisher Scientific Inc, Alere Inc, Siemens AG, F-Hoffmann La Roche, Nihon Kohden Corporation, Sysmex Corporation, Helena Laboratories, International ...

  • World
  • APAC
  • Blood Disease
  • Industry analysis


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on